Novus Therapeutics Announces Acquisition of Anelixis Therapeutics

Novus Therapeutics Announces Acquisition of Anelixis Therapeutics

4.5
(254)
Write Review
More
$ 19.00
Add to Cart
In stock
Description

The Daily Biotech Pulse: Marinus Epilepsy Study Meets Goal, Novavax Reaches Vaccine Manufacturing Deal, Outset Medical's IPO

Novus Therapeutics (@Novus_Thera) / X

A Tribute to Bill Sr.

DEF 14A

Amanda Sellers's Instagram, Twitter & Facebook on IDCrawl

Novus - Recent News & Activity

Eledon Pharmaceuticals Reports Fourth Quarter and Full-Year 2020 Operating and Financial Results

News & Events - Noble Capital Markets

Vaderis Therapeutics AG Emerges from Stealth and Announces Initiation of Clinical Proof-of-Concept Trial in HHT

Augie's Quest Brings ALS Drug Option to OC - Orange County Business Journal

Novus Therapeutics (@Novus_Thera) / X

SEC Filing Kiniksa Pharmaceuticals

DEF 14A

Eledon Pharmaceuticals acquires Anelixis Therapeutics - 2020-09-14 - Crunchbase Acquisition Profile

SEC Filing Eledon Pharmaceuticals, Inc.